TATRADER GIZZARD STUDY--Stocks 12.00 or Less..... Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : TATRADER GIZZARD STUDY--Stocks 12.00 or Less.....

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nolimitz who wrote (56808)	11/29/2006 8:14:20 AM
From: joseffy	Read Replies (1) of 59879

Dynavax Technologies (DVAX) shares are expected to jump after it reported statistically significant results of a Phase III trial comparing hepatitus B vaccine Heplisav to Glaxo's Energix-B vaccine. (Dow Jones) By Steve Goldstein

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next